CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4/A Open-market sale Chief Tech. Operations Officer sold 500 shares at $38.44 ($19,220)
- 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
- 4 Grant or award Senior VP & General Counsel acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Tech. Operations Officer acquired 15,000 shares (grant or award)
- 4 Grant or award Global Head of R&D acquired 15,000 shares (grant or award)
- 4 Grant or award SVP, Head of Global Commercial acquired 10,000 shares (grant or award)
- 4 Open-market sale Director sold 20,000 shares at $38.25 ($765,000)
- 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $39.48 ($307,953)
- 4 Open-market sale Chief Tech. Operations Officer sold 1,500 shares at an average $36.13 ($54,202)
- 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $36.14 ($281,891)
- 4 Open-market sale Director sold 62,590 shares at $36.07 ($2,257,621)
- 4/A Grant or award Director acquired 1,500 shares (grant or award)
- 4 Open-market sale EVP, R&D & Chief Scientific Of sold 775 shares at $39.59 ($30,682)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,176 shares (to pay taxes)
- 4 Open-market sale SVP, Head of Global Commercial sold 5,909 shares at $40.00 ($236,360)
- 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $38.77 ($302,367)
- 4/A Shares withheld for taxes Chief Executive Officer gave up 24,683 shares (to pay taxes)
- 4 Open-market sale EVP, R&D & Chief Scientific Of sold 13,975 shares at $38.55 ($538,736)
- 4 Grant or award Chief Financial Officer acquired 17,063 shares (grant or award)
- 4 Open-market sale EVP, R&D & Chief Scientific Of sold 12,375 shares at an average $38.62 ($477,922)
Page 14 of 33 · 645 filings